Ovarian characteristics and timed artificial insemination pregnancy risk after presynchronization with gonadotropin-releasing hormone 7 days before PGF2α in dairy cows.
The objective was to determine the benefit of including GnRH and PGF2α (PG) as a part of a presynchronization option before enrolling cows in a timed artificial insemination (AI) program. Holstein cows in one herd were assigned weekly at calving from January 2012 to August 2014 to a completely randomized design consisting of two presynchronization treatments. Cows in the Presynch-11 (n = 290) control were administered two PGF2α injections (Presynch PG-1 and Presynch PG-2) 14 days apart starting at 39 ± 4 days postpartum (study Days 0 and 14). Cows receiving the experimental presynchronization treatment (Gsynch-11, n = 287) were treated with GnRH (pre-GnRH) on study Day 7 and PG (pre-PG) on study Day 14. On study Day 25, all cows were enrolled in the Ovsynch-56 timed AI program: GnRH-1 on study Day 25, PG on study Day 32, GnRH-2 on study Day 34, 56 hours after PG, and timed AI on study Day 35, 16 hours after GnRH-2. In a subsample of 255 cows, ovarian structures were monitored for size and ovulation, and blood samples were collected on study Days 7, 14, 25, 32, 34, and 41 to measure progesterone. Concentrations of progesterone were greater (P < 0.05) in Gsynch-11 than Presynch-11 cows before pre-GnRH was administered (3.3 ± 0.3 vs. 2.1 ± 0.3 ng/mL), respectively, and ovulatory response to the pre-GnRH treatment also was greater (P = 0.008) in Gsynch-11 than Presynch-11 cows (53.2 vs. 35.0%), respectively. One week later, the dominant follicle was larger (P = 0.045) in Presynch-11 than Gsynch-11 cows. Eleven days after completing the presynchronization treatments, ovulatory response to the Ovsynch GnRH-1 treatment was greater (P = 0.016) in Presynch-11 than Gsynch-11 cows (62.2% vs. 45.6%), respectively. At the time of the Ovsynch-PG treatment, more (P = 0.019) Presynch-11 than Gsynch-11 cows had at least one CL. Subsequent luteal regression (>96%), ovulation to GnRH-2 (>90%), and synchronization risk (>88%) did not differ between treatments, but incidence of multiple ovulation after GnRH-2 was larger (P = 0.036) in Presynch-11 than Gsynch-11 cows (28.4% vs. 15.9%), respectively. Pregnancy per AI at 32 days (36.4% vs. 35.1%) and 60 days (30.0% vs. 29.0%) after AI did not differ between Gsynch-11 and Presynch-11 cows, respectively, but was suppressed during summer months in both treatments to less than 70% of the pregnancy per AI of nonsummer months. Because more than 90% of the cows were ovular as treatments were applied, the GnRH treatment of Gsynch-11 could not be assessed for its benefit in anovular cows. The Gsynch-11 presynchronization treatment performed comparably with the standard Presynch-11 program and provides a viable presynchronization option for use before first AI in dairy herds.